Search results
Biogen (BIIB) Slipped on Lower-Than-Expected Revenue Growth
Insider Monkey via Yahoo Singapore Finance· 1 day agoClearBridge Investments, an investment management company, released its “ClearBridge Value Equity...
Eli Lilly (LLY) Gets FDA Nod for Alzheimer's Drug Donanemab
Zacks via Yahoo Singapore Finance· 8 hours agoEli Lilly's (LLY) Alzheimer's disease drug, Kisunla (donanemab), wins FDA approval. Kisunla will be...
Eli Lilly Alzheimer's drug approved by US FDA
Reuters via Yahoo Singapore Finance· 1 day ago(Reuters) -The U.S. Food and Drug Administration on Tuesday approved Eli Lilly's treatment for early Alzheimer's, making it the second therapy for...
Eisai and Biogen launch Alzheimer's drug Leqembi in China
Reuters via Yahoo Singapore Finance· 6 days agoLeqembi, which works by removing a toxic protein called beta amyloid from the brain, is the first...
FDA approves donanemab, Eli Lilly’s treatment for early Alzheimer’s disease
CNN via Yahoo News Singapore· 1 day agoThe US Food and Drug Administration on Tuesday approved donanemab, a monoclonal antibody designed to slow the progression of early symptomatic Alzheimer’s disease.
FDA Approves Second Alzheimer’s Drug after Trial Shows it Can Slow Disease by 35%
The Daily Beast via Yahoo News Singapore· 20 hours agoThe Federal Drug Administration gave the go-ahead to a second Alzheimer’s treatment Tuesday after a...
Denali (DNLI) Outperforms Industry in 3 Months: Here's Why
Zacks via Yahoo Singapore Finance· 5 days agoThe pipeline progress has been encouraging. DNLI has collaborations with bigwigs like Biogen BIIB...
FDA approves Lilly’s new Alzheimer’s drug after delay
The Hill via Yahoo News Singapore· 1 day agoThe Food and Drug Administration (FDA) on Tuesday approved Eli Lilly’s Alzheimer’s drug, the company...
FDA approves a second Alzheimer's drug that can modestly slow disease
Associated Press Finance via Yahoo Singapore Finance· 1 day agoU.S. officials have approved another Alzheimer’s drug that can modestly slow the disease, providing...
In new Alzheimer’s criteria, some see progress while others fear profit-driven ‘diagnostic creep’
CNN via Yahoo News Singapore· 2 days agoWith a second pricey drug to treat Alzheimer’s disease set to receive an approval decision soon, the...